Literature DB >> 15531095

Relationship between suicidal behavior of psychotic inpatients and serotonin transporter gene in Han Chinese.

Yifeng Shen1, Huafang Li, Niufan Gu, Zheng Tan, Junxia Tang, Jinbo Fan, Xingwang Li, Wei Sun, Lin He.   

Abstract

Strong evidence indicates that central serotoninergic system dysfunction is associated with suicidal behavior. The relationship between the serotonin transporter protein (5-HTT) gene of psychotic patients in Han Chinese with suicidal behavior was studied since the 5-HTT plays an important role in serotoninergic transmission. Two hundred and seventy-two psychotic inpatients with suicidal behavior (suicide group) and 275 psychotic inpatients without suicidal behavior (patient control group) were recruited from six mental health facilities in Shanghai, China. Another 628 healthy adults (healthy control group) without suicidal behavior and mental disorder history were enrolled from Shanghai, China. All subjects were Han Chinese. The genotypes and the alleles of 5-HTT genes of the three groups were examined by PCR amplification. Neither the intron 2 variable number tandem repeat (VNTR) polymorphism and 5-HTTLPR (5-HTT gene-linked polymorphic region), nor the haplotype frequencies of this gene have significant differences between the suicide group and the two control groups. However, there was a significant difference in 5-HTTLPR polymorphism between inpatients with a first episode of suicidal behavior and those with recurrent suicidal behavior. Except for the possible heterogeneity between inpatients with a first episode of suicidal behavior and those with more than one, the 5-HTT gene was unlikely to be associated with suicidal behavior of psychotic patient in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531095     DOI: 10.1016/j.neulet.2004.09.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Psychosocial mechanisms of serotonin transporter's genetic polymorphism in susceptibility to major depressive disorder: mediated by trait coping styles and interacted with life events.

Authors:  Yanfang Wang; Ning Sun; Zhifen Liu; Xinrong Li; Chunxia Yang; Kerang Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  The serotonin transporter polymorphism (5-HTTLPR): allelic variation and links with depressive symptoms.

Authors:  Noreen Goldman; Dana A Glei; Yu-Hsuan Lin; Maxine Weinstein
Journal:  Depress Anxiety       Date:  2010-03       Impact factor: 6.505

Review 3.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

4.  Possible Association between Serotonin Transporter Gene Polymorphism and Suicide Behavior in Major Depressive Disorder.

Authors:  Hwa-Young Lee; Jin-Pyo Hong; Jung-A Hwang; Heon-Jeong Lee; Ho-Kyung Yoon; Bun-Hee Lee; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

5.  Evaluation of the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene in females with postpartum depression.

Authors:  Xiaoli Zhang; Lin Wang; Fenghua Huang; Jiafu Li; Li Xiong; Han Xue; Yuanzhen Zhang
Journal:  Exp Ther Med       Date:  2014-10-31       Impact factor: 2.447

6.  Interaction between a serotonin transporter gene promoter region polymorphism and stress predicts depressive symptoms in Chinese adolescents: a multi-wave longitudinal study.

Authors:  Qing-sen Ming; Yun Zhang; Qiao-lian Chai; Hai-yan Chen; Chan-juan Hou; Meng-cheng Wang; Yu-ping Wang; Lin Cai; Xiong-zhao Zhu; Jin-yao Yi; Shu-qiao Yao
Journal:  BMC Psychiatry       Date:  2013-05-17       Impact factor: 3.630

7.  Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Authors:  R Rajkumar; R Mahesh
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.